The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis
Abstract
This study aims to estimate the reliable prevalence of fibromyalgia using meta-analysis method. Available databanks were searched using appropriate keywords. According to the heterogeneity between the results (indicated by Cochrane and I square indices), random- or fixed-effects model was applied to combine the point prevalences. Meta-regression models were used to assess the suspected factors in the heterogeneity. In 65 selected papers, 81 evidences regarding prevalence of fibromyalgia among 3,609,810 subjects from general population and specific groups were investigated. The total prevalences (95% confidence intervals) of fibromyalgia among general population, women, men, patients referring to rheumatology and internal departments, patients with Irritable bowel syndrome (IBS), hemodialysis patients and those with type 2 diabetes mellitus were estimated as of 1.78% (1.65, 1.92), 3.98% (2.80, 5.20), 0.01% (-0.04, 0.06), 15.2% (13.6, 16.90), 12.9% (12.70, 13.10), 6.30% (4.60, 7.90) and 14.80% (11.10, 18.40), respectively. In addition, prevalence of fibromyalgia in specified groups varied from 3.90% in hemodialysis patients to 80% in patients suffering from Behcet syndrome. This meta-analysis showed that prevalence of fibromyalgia in general population was significantly lower than that in populations with some diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“در برخی مطالعات، شیوع فیبرومیالژیا در زنان 6 تا 10 برابر بیشتر از مردان گزارش شده است ] 3 [ .”
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.08.012 · Cited by 2,698
Prevalence of Fibromyalgia: A Survey in Five European Countries
Branco, J. C., Bannwarth, B., Failde, I., Abello Carbonell, J., Blotman, F., Spaeth, M., Saraiva, F., Nacci, F., Thomas, E., Caubère, J.-P., et al. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.12.003 · Cited by 685
Bennett, R. M. (2005) · PubMed · Cited by 616
The prevalence of chronic widespread pain in the general population.
Croft, P. R., Rigby, A. S., Boswell, R., Schollum, J. B. W., & Silman, A. J. (1993) · PubMed · Cited by 474
Jones, G. T., Atzeni, F., Beasley, M., Flüß, E., Sarzi‐Puttini, P., & Macfarlane, G. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38905 · Cited by 468
Wolfe, F., Brähler, E., Hinz, A., & Häuser, W. (2013) · Arthritis Care & Research · doi:10.1002/acr.21931 · Cited by 443
Vincent, A., Lahr, B. D., Wolfe, F., Clauw, D. J., Whipple, M. O., Oh, T. H., Barton, D. L., & Sauver, J. L. S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21896 · Cited by 385
The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey
Walitt, B., Nahin, R., Katz, R., Bergman, M., & Wolfe, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138024 · Cited by 274
Research works printed but not linked: 1
- Ablin JN, Oren A, Cohen S, Aloush V, Buskila D, Elkayam O et al (2012) Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol 30(6 Suppl 74):39–43
Cited by
Sorted by citations
Items 201–300 of 400
Côté, C. (2022) · GLAD! · doi:10.4000/glad.5570 · Cited by 7
Hansson, K. S., Lindqvist, G., Stening, K., Fohlman, J., Wojanowski, A., Pontén, M., Jensen, K. B., Gerdle, B. U. C., & Elmqvist, C. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066987 · Cited by 4
Protocol of HOTFy: randomised clinical trial to hyperbaric oxygen therapy in fibromyalgia
Neto, J. D. M., Mendes, A. F., Martins, A. F. M., de Landa, A. T., Fraga, R. D. O., de Souza, V. A., & Raposo, N. R. B. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069153 · Cited by 3
Norouzi, E., Pournazari, M., Joybari, T. A., Sufivand, P., Asar, S., Bratty, A. J., & Khazaie, H. (2025) · Current Psychology · doi:10.1007/s12144-025-07808-w · Cited by 3
“In Iran, prevalence is even higher, ranging from 3 to 20% (Heidari et al., 2017).”
Vancampfort, D., de Bruin, E. D., Bernar, K., Hemmings, L., & Damme, T. V. (2025) · Clinical Rehabilitation · doi:10.1177/02692155251351899 · Cited by 3
Structured Short-Term Group Art Therapy in Patients with Fibromyalgia. A Pilot Study
Rüütel, E., Kruus, K., Ivanova, A., & Laas, K. (2019) · Reabilitacijos mokslai slauga kineziterapija ergoterapija · doi:10.33607/rmske.v1i18.753 · Cited by 3
“A recent study (Heidari et al., 2017) showed that the prevalence of FM among the general population is considerably lower than that of populations with specific disorders, e.g. in patients referred to rheumatology clinics and among patients with irritable bowel syndrome, haemodialysis and type 2…”
BackgroundRodríguez-Castillejo, P. M., Fernández‐de‐las‐Peñas, C., Alburquerque‐Sendín, F., & Rodrigues‐de‐Souza, D. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204776 · Cited by 3
Análisis bibliométrico de la evolución temática en fibromialgia y biomecánica (1985-2021)
Ortega‐Martin, E., Gamero-Lucas, J., & López-Sánchez, J. A. (2022) · Rehabilitación · doi:10.1016/j.rh.2022.02.001 · Cited by 3
Moore, J. W., Guareschi, A. S., Rogalski, B. L., Eichinger, J. K., & Friedman, R. J. (2024) · Seminars in Arthroplasty JSES · doi:10.1053/j.sart.2024.07.009 · Cited by 3
Lizama-Lefno, A., Mojica, K., Roco-Videla, Á., Vargas, J. I., González-Droguett, N., Muñoz-Yánez, M. J., Atenas-Núñez, E., Maureira-Carsalade, N., & Flores-Carrasco, S. V. (2024) · Biomedicines · doi:10.3390/biomedicines12102284 · Cited by 3
“It affects approximately 1.78% of the general population, predominantly affecting women, who are up to four times more likely to be diagnosed compared to men, with prevalence rates in women ranging from 2% to 6%, and it is most commonly diagnosed between the ages of 20 and 55 [1].”
BackgroundInfluentialElgayar, S. L. (2025) · Journal of Physical Activity and Health · doi:10.1123/jpah.2024-0754 · Cited by 4
Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia
Ayoub, S. E., Ahmed, A. M., Abdelwahed, M. Y., Khalefa, A. A., Awaji, A. A., Zekry, S. S., Ibrahim, E. G., Eid, H. M., Elasmer, S. M., & Fares, R. (2025) · European journal of medical research · doi:10.1186/s40001-025-02330-y · Cited by 4
Understanding fibromyalgia: A comprehensive review of the literature
Elsaid, N. Y. (2025) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2025.02.001 · Cited by 4
Is fibromyalgia secondary to rheumatic diseases?
Filatova, E. G., Melikova, N. A., Филатова, Е. С., & Lila, A. M. (2025) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2025-1-49-56 · Cited by 3
Halpin, S. J., Xing, L., Greenwood, D. C., Tang, N., Trujillo‐Barreto, N. J., Brown, C. A., Jones, A. K. P., O’Connor, R. J., Casson, A. J., & Sivan, M. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105393 · Cited by 3
Meral, H. B., Rezvanı, A., Tolu, S., Üşen, A., & Dasdelen, M. F. (2025) · Rheumatology International · doi:10.1007/s00296-025-05871-x · Cited by 4
Aşkın, A., Güvendi, E., Özkan, A., Şimşek, E. Ç., Kocabaş, U., & Tosun, A. (2017) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2018.10 · Cited by 3
Violet, T. K. (2019) · Journal of Medical Humanities · doi:10.1007/s10912-019-09575-9 · Cited by 3
Fibromyalgia syndrome in medical students
Moghazy, A. A., Ibrahim, A. M., Ahmed, H. A., & Abdelnasser, M. (2022) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2022.11.003 · Cited by 3
Del-Río-Guerrero, V., Martínez-Martínez, L.-A., Arias-Callejas, K., Carbonell-Bobadilla, N., Mejía-Segura, A., Azamar-Morales, G. F., Espinosa-Orantes, A., Molina-Sánchez, J.-R., Mora-Ramírez, M., Mejía-Ávila, M.-F., et al. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152218 · Cited by 4
Hyperbaric oxygen therapy for patients with fibromyalgia: a systematic review protocol
Han, X., He, Y., Yuan, X., Sun, N., & Liu, X. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071092 · Cited by 3
Schweiger, V., Martini, A., Nizzero, M., Bonora, E., Balzo, G. D., Gottin, L., Torroni, L., Polati, L., Zuliani, G., Secchettin, E., et al. (2024) · Medicina · doi:10.3390/medicina60040599 · Cited by 3
Exploring Pain Reduction through Physical Activity: A Case Study of Seven Fibromyalgia Patients
Jenssen, M. D. K., Salvi, E., Fors, E. A., Nilsen, O. A., Ngo, P. D., Tejedor, M., Bellika, J. G., & Godtliebsen, F. (2024) · Bioengineering · doi:10.3390/bioengineering11080765 · Cited by 3
Psychometric properties of Polish version of the 36-item WHODAS 2.0 in individuals with fibromyalgia
Ćwirlej-Sozańska, A. B., Sozański, B., Łagowska, A., Wilmowska-Pietruszyńska, A., & Wiśniowska-Szurlej, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-72575-w · Cited by 5
Effect of Repetitive Transcranial Magnetic Stimulation in Male Patients of Fibromyalgia
Tiwari, V. K., Nanda, S., Arya, S., Kumar, U., & Bhatia, R. (2020) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_163_19 · Cited by 3
“[1] ] Since our previous study has shown it to be an effective therapy in female patients with fibromyalgia, [5] we explored the role of repetitive transcranial magnetic stimulation (rTMS) intervention on pain status and related outcomes in male patients.”
InfluentialThe prevalence of fibromyalgia among doctors in the tertiary care hospital: A cross-sectional study
Tahir, S., Zeb, A., Sharif, M., Rehman, O. U., Khan, M. S., Mukhtar, M., Mumtaz, H., & Zubair, A. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104931 · Cited by 3
Fortuna, J., Pinto, A. M., da Silva, J. A. P., Geenen, R., & Castilho, P. (2025) · Journal of Health Psychology · doi:10.1177/13591053251331286 · Cited by 2
“Fibromyalgia is a chronic and multidetermined condition that affects around 1.8% of the general adult population worldwide (Heidari et al., 2017) and greatly impacts individual and social functioning (Arnold et al., 2008; Galvez-Sa´nchez et al., 2019).”
InfluentialSexual desire in women with fibromyalgia: beyond the pain?
Cuevas-Toro, A. M., Díaz, C., & Sánchez-Fuentes, M. D. M. (2025) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdaf123 · Cited by 4
Bothelius, K., Kosek, E., & Jansson‐Fröjmark, M. (2025) · Journal of Sleep Research · doi:10.1111/jsr.70199 · Cited by 2
“Globally, FM affects approximately 2% of the population (Heidari et al. 2017; Queiroz 2013).”
Sahebari, M., Tahmasbi, F., & Rahimi-Mamaghani, A. (2025) · Pain Medicine · doi:10.1093/pm/pnaf133 · Cited by 2
Lizama-Lefno, A., Roco-Videla, Á., Atenas-Núñez, E., González-Droguett, N., Muñoz-Yánez, M. J., & Flores-Carrasco, S. V. (2025) · Healthcare · doi:10.3390/healthcare13233143 · Cited by 2
“Its estimated prevalence ranges from 0.2% to 4.7%, predominantly among women [5–8].”
InfluentialPrevalence and predictors of fibromyalgia symptoms in an academic setting: a cross-sectional study
Alshareef, M. H., Almutair, G., Hafiz, W. A., Ibrahim, S., Hariri, N. H., & Shatla, M. M. (2025) · BMC Rheumatology · doi:10.1186/s41927-025-00610-y · Cited by 3
“This finding aligns with the results of several studies that have highlighted a higher prevalence of FM symptoms among women [15, 16].”
Tattan, M., Gol, J. M., van Tol, D. G., Hanssen, D. J. C., & Rosmalen, J. G. M. (2026) · Journal of Health Psychology · doi:10.1177/13591053251409603 · Cited by 2
“The mechanisms and aetiology of fibromyalgia remain largely unknown (Perrot, 2019; Siracusa et al., 2021) despite it being a commonly seen condition with a worldwide prevalence of 1.8% (Heidari et al., 2017).”
InfluentialFibromyalgia: A Multifactorial Pain Disorder
Aoe, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114813 · Cited by 2
¿Es la fibromialgia causa de fracaso de una descompresión subacromial artroscópica?
Lópiz, Y., Marcelo, H., Arvinius, C., Rodríguez‐Rodríguez, L., Fernández, C. I., & Marco, F. (2019) · Revista Española de Cirugía Ortopédica y Traumatología · doi:10.1016/j.recot.2019.03.001 · Cited by 2
Serum anti-neural immunoreactivity in patients with fibromyalgia. Preliminary study
de la Cruz-Aguilera, D. L., Cabrera, D. M., Rodríguez-Pérez, C. E., Martínez‐Flores, F., Hernández, M. E., Becerril‐Villanueva, E., Pérez‐Sánchez, G., Pavón, L., & Aguirre‐Cruz, L. (2022) · Gaceta Médica de México · doi:10.24875/gmm.m22000649 · Cited by 2
The effectiveness of major ozone autohemotherapy in the treatment of fibromyalgia syndrome
Ahi, E. D., & Afşar, S. İ. (2022) · Journal of Surgery and Medicine · doi:10.28982/josam.1032050 · Cited by 2
“78% with a predominant ratio of women to men [2].”
BackgroundIdentification of the Involvement of Potassium Channels in Fibromyalgia
Lawson, K. (2022) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1404029 · Cited by 2
“Fi-bromyalgia, dependent on the diagnostic criteria and meth-ods of classification, is estimated to affect 0.4–8% of the population worldwide with prevalence greater in females and increasing with age [4].”
BackgroundInfluentialAngelats, R. C., Martín, C. A., Carrasco-Querol, N., Abellana, R. M., Serra, G. G., Benaiges, D. G., Sol, M. C. S., Anguera, I. F., Jordana, S. C., Berenguera, A., et al. (2023) · Healthcare · doi:10.3390/healthcare12010017 · Cited by 2
“[2].”
Current Views on the Relationship between Fibromyalgia and Mental Disorders
Zinchuk, M. S., Turchinets, A., Tumurov, D. A., Zhuravlev, D., Bryzgalova, J. E., & Guekht, A. B. (2024) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-024-01603-z · Cited by 2
Atenas-Núñez, E., Muñoz-Yánez, M. J., Lizama-Lefno, A., Roco-Videla, Á., & Caviedes-Olmos, M. (2024) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt20241179 · Cited by 2
Subgrouping fibromyalgia according to prevalence data may lead to a new therapeutic concept
Schirmer, M. (2017) · Rheumatology International · doi:10.1007/s00296-017-3840-0 · Cited by 2
Savall, A., Dieudonné, M., Lazzari, M. D., Hassam, R., & Cathébras, P. J. (2019) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2019.02.007 · Cited by 2
Consciência perineal, presença de sintomas urinários e satisfação sexual na fibromialgia
Marcondes, J. C., Rodrigues, É., & Salerno, G. R. F. (2021) · Fisioterapia Brasil · doi:10.33233/fb.v22i3.4519 · Cited by 2
Walker, C. I. B., Figueiredo, R. F., Costa, A. T., Silva, R. D. O. S., da Silva, T. D., Alcântara, T. D. S., & de Lyra, D. P. (2022) · Current Rheumatology Reviews · doi:10.2174/1573397118666220318105002 · Cited by 2
Fibromiyalji ile İlişkili Psikolojik Faktörler ve Psikolojik Müdahale Alanları
TEZCAN, R. E. K., & Alkar, Ö. Y. (2022) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.972163 · Cited by 5
Etiology and pathophysiology of fibromyalgia
Almanza, A. P. M. C., da Cruz, D. S., de Oliveira-Junior, S. A., & Martinez, P. F. (2023) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v13i3.1420 · Cited by 2
“Outros procedimentos para diagnóstico de fibromialgia foram documentados em estudos científicos, incluindo-se inquéritos, como Questionário do Impacto da Fibromialgia, London Fibromyalgia Epidemiology Study Screening Questionnaire 11 e Critérios do ACTTION-APS Pain Taxonomy 12 .”
BackgroundLomas‐Vega, R., Ogáyar, C. J., Segura, R. J., Rueda, A. J., Osuna‐Pérez, M. C., & Peinado-Rubia, A. B. (2023) · Applied Sciences · doi:10.3390/app131910579 · Cited by 2
[Modern ideas about the relationship between fibromyalgia and mental disorders].
Zinchuk, M., Turchinets, A., Tumurov, D., Zhuravlev, D., Bryzgalova, J. E., & Guekht, A. (2023) · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · doi:10.17116/jnevro20231231017 · Cited by 2
Hijne, K., Gerritsen, L., Pinto, A. M., da Silva, J. A. P., van der Sluijs, J. F. V. E., & Geenen, R. (2023) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2023.100420 · Cited by 2
“A greater female prevalence is common in both CSS (e.g., Lim et al., 2020; Heidari et al., 2017; Lovell & Ford, 2012) and most RMD (e.g., Branco et al., 2016).”
BackgroundRECURSOS TERAPÊUTICOS PARA A FIBROMIALGIA: UMA REVISÃO SISTEMÁTICA
de Melo, G. A., Araújo, G. D. L., de Vasconcelos, A. M., et al. (2020) · Revista Contexto & Saúde · doi:10.21527/2176-7114.2020.38.49-56 · Cited by 2
Akbarian, M., PhD Candidate, D. O. H. P., Saeidi, N., MSc, D. O. M. H., Borjali, A., Professor, D. O. C. P., Abolghasemi, S., Assistant Professor, D. O. I. M., Hassanabadi, H. R., & Associate Professor, D. O. E. P. (2022) · Avicenna Journal of Clinical Medicine · doi:10.52547/ajcm.28.4.244 · Cited by 1
ŞENER, Ö. (2022) · Cyprus Turkish Journal of Psychiatry and Psychology · doi:10.35365/ctjpp.22.4.07 · Cited by 1
Positive Affect Moderates Walking's Impact on Depression in Fibromyalgia Patients
Écija, C., Catalá, P., Gutiérrez, L., & Peñacoba, C. (2025) · Pain Management Nursing · doi:10.1016/j.pmn.2025.02.002 · Cited by 2
Falaguera-Vera, F. J., Torralba-Estellés, J., Mampel, J. V., Ferrer‐Torregrosa, J., Oltra, E., & Garcia-Escudero, M. (2025) · Healthcare · doi:10.3390/healthcare13070764 · Cited by 1
“FM occurs more frequently in women between 20 and 55 years of age and shows an increase with advancing age, affecting approximately 7.4% of women between 70 and 79 years of age [3].”
InfluentialPinto, A. M., Marques, C., Figueiredo, C., Caramelo, F. J., Luís, M., Castilho, P., Geenen, R., & da Silva, J. A. P. (2025) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.70130 · Cited by 1
Prevalence of fibromyalgia in asthma and its impact on asthma control: a case-control study
Konuk, S., Özel, A., Özsarı, E., & Nasırcılar, A. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2566392 · Cited by 1
“The literature on this topic presents conflicting findings; while some studies suggest that female sex is a risk factor for fibromyalgia [16], others have reported no significant sex-related differences in fibromyalgia prevalence [18].”
InfluentialBorze, T. F., Pallag, A., CIOBANU, D. I., Kalman, K., Ciurba, A.-P., Suciu, R. N., Muresan, M. E., & Nistor-Cseppento, C. D. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22101553 · Cited by 1
“Fi-bromyalgia Fi-bromyalgia affects between 0.2% and 6.6% of the world’s population, particularly women between the ages of 30 and 50 [3,4].”
InfluentialCaumo, W., Pacheco‐Barrios, K., Lacerda, G. J. M., França, B. R., & Fregni, F. (2025) · European Journal of Pain · doi:10.1002/ejp.70145 · Cited by 1
“Fibromyalgia (FM) is a chronic pain syndrome affecting 2%–8% of the global population (Heidari et al. 2017), characterised by widespread musculoskeletal pain, fatigue and cognitive disturbances, which markedly impair quality of life (Häuser et al. 2015).”
Silva, H. L., Santos, A. A. F., Monteiro, A. B., Sousa, M. R., & Rodrigues, J. M. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00865-3 · Cited by 1
“…estimate a global prevalence of 1.25–5%, with higher rates among women (Queiroz 2013; Creed 2020; Sarzi-Puttini et al. 2020; Jiao et al. 2021; Sauch Valmana et al. 2022; Duhn et al. 2024), although some reports suggest underdiagnosis in men may obscure prevalence estimates (Heidari et al. 2017).”
InfluentialFoustoukos, T. L., Leclercq, I., Blanchard, M., & Hügle, T. (2025) · Interactive Journal of Medical Research · doi:10.2196/67523 · Cited by 1
Ağırman, M., Cantürk, İ. A., & Üşen, A. (2025) · Rheumatology International · doi:10.1007/s00296-025-06040-w · Cited by 1
Denche-Zamorano, Á. M., Salas-Gómez, D., Vega-Muñoz, A., Tomás-Carús, P., Castillo-Paredes, A., Parraça, J. A., & Adsuar, J. C. (2026) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-025-00368-8 · Cited by 1
“FM is estimated to affect approximately 2–4% of the general population [9, 10], although some research suggests that prevalence could be as high as 8% worldwide [9, 10].”
Starks, V. A., Toussaint, L. L., Sirois, F. M., Dezutter, J., Schelling, J., Kohls, N., Offenbächer, M., & Hirsch, J. K. (2026) · Journal of Behavioral Medicine · doi:10.1007/s10865-026-00632-y · Cited by 1
“…and females which, although reflective of clini - cal cohorts, is indicative of well-established diagnostic and access-related health disparities (Heidari et al., 2017 ; Marques et al., 2017; Walitt et al., 2016); thus, our findings may not be generalizable to other demographic and patient…”
Uthman, I. W., Ghzayel, L., Semaan, Z. M., Sarkis, V., Labibidi, G., Moussawi, M. A., Daou, A. M., Feghali, P. A. R., Zeineddine, N., & Hamdan, A. (2026) · Journal of Voice · doi:10.1016/j.jvoice.2026.01.022 · Cited by 1
Ferrari, L. F., Wilkinson, A., Ramirez, A., Kuchenbecker, J. A., Jay Neitz, A., Mauck, M., & Taylor, N. E. (2025) · Pain · doi:10.1097/j.pain.0000000000003883 · Cited by 1
Predicting Nonresponse to Multicomponent Treatment in Fibromyalgia
López-García, R., Serrat, M., Sanabria‐Mazo, J. P., Pérez‐Aranda, A., Almirall, M., Delgadillo, J., Espelt, A., Luciano, J. V., Nieto, R., & Feliu‐Soler, A. (2026) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000001367 · Cited by 1
Cavicchioli, M., Nimbi, F. M., Bottiroli, S., Guglielmi, D., Castelli, L., & Galli, F. (2026) · Pain Research and Management · doi:10.1155/prm/8005108 · Cited by 1
“Nevertheless, individuals with fbromyalgia also experience other distressing somatic and cognitive-afective symptoms, such as fatigue, sleep disturbances, cognitive impairment, and emotional distress [11–13].”
Brink, A., Mogård, E., Lindqvist, E., Sagard, J., Roseman, C., Geijer, M., Olsen, J. K., Wallman, J. K., & Olofsson, T. (2026) · Rheumatology International · doi:10.1007/s00296-026-06140-1 · Cited by 1
HOTFy: randomised clinical trial for hyperbaric oxygen therapy in fibromyalgia
Neto, J. D. M., Junior, A. F. [. M., Martins, A. F. M., de Landa, A. T., Fraga, R. C., de Souza, V. A., & Raposo, N. R. B. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-112284 · Cited by 1
Carmona, L., Kloppenburg, M., Nikiphorou, E., Sharma, A., Oancea, A., Home, R. D., & Green, F. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.05.015 · Cited by 1
Towards an individualised approach to pain management in inflammatory arthritis
Rutter‐Locher, Z., Denk, F., Taams, L. S., Kirkham, B. W., & Bannister, K. (2026) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x261452012 · Cited by 1
Prevalence of Rheumatic Disorders in Geriatric Population
Hirsch, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-44234-7_1 · Cited by 1
Fibromyalgia Syndrome in Patients with Type 2 Diabetes Mellitus
Cüzdan, N., Akkuş, G., Sarpel, T., Sert, M., & Nazlıcan, E. (2022) · Cyprus Journal of Medical Sciences · doi:10.4274/cjms.2020.2928 · Cited by 1
“FMS prevalence is found to be higher in specific populations such as inflammatory bowel disease, chronic hepatitis C, hyperprolactinemia and hemodialysis patients and diabetes mellitus.(7) Diabetes mellitus (DM) type 2 is also a chronic disease, mainly characterized by sensorial abnormalities which can mimic the”
BackgroundEzgi, T. U. N. A. (2023) · Klinik Psikoloji Dergisi · doi:10.57127/kpd.26024438m000084x · Cited by 1
Acupuncture for fibromyalgia: An evidence map 针灸治疗纤维肌痛:证据图
Shi, L.-J., Hu, X.-Y., Tian, Z., et al. (2023) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2023.07.001 · Cited by 1
Zinchuk, M., Kustov, G., Tumurov, D. A., Zhuravlev, D., Bryzgalova, Y., Spryshkova, M., Yakovlev, A. A., & Guekht, A. B. (2024) · European Journal of Pain · doi:10.1002/ejp.4730 · Cited by 3
“We found that the prevalence of FM in patients with non-psychotic mental disorders was higher than that found in the meta-analysis by Heidari et al. (2017) for the general population (1.78%).”
InfluentialGoel, A. (2019) · Annals of Internal Medicine · doi:10.7326/acpjc-2019-170-2-011 · Cited by 1
“8%) and patients with such chronic diseases as rheumatologic disorders (15%) and irritable bowel syndrome (13%) (1).”
BackgroundGorial, F. I., Ahmad, W. S., & Abbood, H. S. (2021) · Archives of Medical Science - Civilization Diseases · doi:10.5114/amscd.2021.109683 · Cited by 1
“This finding is in agreement with 9 previous studies and with a one in 2017 for patients suffering from the same problem, in which the prevalence of FMS among women was 8–9-fold greater than that among men, and pain and disability were as high as in RA, which affects the personal activity and recreation, leading to oc…”
Inmunorreactividad antineural sérica en pacientes con fibromialgia. Estudio preliminar
de la Cruz-Aguilera, D. L., Cabrera, D. M., Rodríguez-Pérez, C. E., Martínez‐Flores, F., Hernández, M. E., Becerril‐Villanueva, E., Pérez‐Sánchez, G., Pavón, L., & Aguirre‐Cruz, L. (2022) · Gaceta Médica de México · doi:10.24875/gmm.21000638 · Cited by 1
Sanabria‐Mazo, J. P., Serrat, M., Canedo, C. M., Feliu‐Soler, A., Almirall, M., Méndez-Ulrich, J. L., Luciano, J. V., & Sanz, A. (2020) · doi:10.31234/osf.io/hyc86 · Cited by 1
Fibromyalgia syndrome and myofascial pain syndromes
Häuser, W., & Fitzcharles, M. (2022) · Wiley eBooks · doi:10.1002/9781119701170.ch30 · Cited by 1
Evidence for nonprescription analgesics in fibromyalgia treatment remains limited
Hemstreet, B. A. (2018) · Pharmacy Today · doi:10.1016/j.ptdy.2018.03.011
Periton Diyalizi ve Hemodiyaliz Uygulanan Hastalarda Fibromiyalji Sendromu
Sargın, G., Şentürk, T., & Akdam, H. (2018) · Sakarya Medical Journal · doi:10.31832/smj.421257
Dyspareunia in Female Fibromyalgia patients
Hefny, M., Abdelnaby, M., Moneim, N. H. A., et al. (2019) · Evidence Based Women s Health Journal · doi:10.21608/ebwhj.2019.45501
“Fibromyalgia (FM) syndrome is one of the most common musculoskeletal disorders with unknown cause involving adults especially women aged 20–55[2].”
BackgroundStaud, R. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-805408-6.00035-x
Understanding Fibromyalgia 2020
Schreibman, C. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2020.09.002
The challenge of painful fibromyalgia – cervical exam to improve the therapeutic approach?
Schirmer, M. (2020) · Archives of Rheumatology & Arthritis Research · doi:10.33552/arar.2020.01.000507
“From epidemiological data we know that FM is diagnosed more often in patients with migraine (31%), physical injury and extreme stress (15%) or cervical radiculopathy (12%) [1].”
BackgroundMaladie de Lyme : « la fin des controverses ? »
Coiffier, G., & Tattevin, P. (2021) · Revue du Rhumatisme · doi:10.1016/j.rhum.2020.12.002
Connors, C., Gott, M. L., & Slotman, G. J. (2020) · Advances in Obesity Weight Management & Control · doi:10.15406/aowmc.2020.10.00315
“(%) Probability Mental Health Diagnosis 14,779 (11) 2,410 (7) <.”
BackgroundConsideration of Fibromyalgia in the Assessment and Treatment of SLE
Fung, W. A., & Touma, Z. (2021) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-021-00181-2 · Cited by 1
“As mentioned previously, fibromyalgia is prevalent amongst SLE patients, with estimates ranging from 15–20% (4, 5).”
BackgroundTsai, P., Kang, J., Chiu, H., Wang, M., & Fang, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00095-5
The Functional Syndromes as Fibromyalgia Comorbidities
Atzeni, F., Gerratana, E., Masala, I. F., & Alciati, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-78638-0_12
Toda, K. (2021) · Trends journal of sciences research · doi:10.31586/ojms.2021.145
“The prevalence of FM is approximately 2% [3].”
BackgroundSeyedmardani, S. M., Abkhiz, S., Megrazi, A., et al. (2021) · Current Rheumatology Reviews · doi:10.2174/1573397117666211021170438
Alves, J. S., Amorim, P. B., Santos, A. G. D. S., et al. (2021) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v2i10.811
Fibromyalgiesyndrom – Pathophysiologie
Broscheit, J. (2022) · Deutsche Zeitschrift für Akupunktur · doi:10.1007/s42212-021-00436-y
Fibromyalgia in patients with migraine: A literature review in the last 20 years
Fortes, Y. M. L., Souza, W. P. D. O., & Silva‐Néto, R. P. (2022) · Headache Medicine/Revista Headache Medicine · doi:10.48208/headachemed.2021.44
Toda, K. (2018) · Austin Journal of Surgery · doi:10.26420/austinjsurg.2018.1148
“The prevalence of fibromyalgia (FM) is approximately 2% [1], and the prevalence of Chronic Widespread Pain (CWP) (incomplete form or early stage of FM) is approximately 10% [2], and the prevalence of Chronic Regional Pain (CRP) (incomplete form or early stage of CWP) is at least the prevalence of CWP worldwide [3].”
Background
Metadata
- Authors
- Heidari, F., Afshari, M., & Moosazadeh, M.
- Affiliations
- Mazandaran University of Medical Sciences (IR)
- Zabol University of Medical Sciences (IR)
- Corresponding author
- Moosazadeh, Mahmood
- Venue
- Rheumatology International
- Published
- 2017-04-26
- Volume
- 37
- Issue
- 9
- Pages
- 1527-1539
- ISSN
- 0172-8172 (ISSN-L)
- 1437-160X
- OpenAlex
- W2609172362
- Cited by
- 432
- References
- 76
- Citations by year
- 2026: 61 · 2025: 68 · 2024: 69 · 2023: 51 · 2022: 53 · 2021: 58 · 2020: 34 · 2019: 24 · 2018: 8 · 2017: 6
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Rheumatology International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Myofascial pain diagnosis and treatment
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- fibromyalgia, prevalence, general population, sex differences, hemodialysis patients, Behçet's disease, irritable bowel syndrome, type 2 diabetes, comorbidities, rheumatology patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Fibromyalgia, Humans, Male, Middle Aged, Risk Factors, Comorbidity, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review